COLORECTAL CANCER SCREENING MARKET ANALYSIS

Regional Analysis

To learn more about this report, request sample copy

North America remains the dominant region in the global colorectal cancer screening market and is estimated to hold 37.4% of the market share in 2024. The presence of leading medical device manufacturers and biotechnology companies in the U.S. has enabled advanced technological development. Favorable reimbursement policies for cancer screening and increasing awareness through initiatives by government and non-profit organizations have boosted adoption rates in the region. Stringent screening guidelines by bodies such as the United States Preventive Services Task Force have made regular screening routine for the population over 50 years of age.

Asia Pacific is poised to emerge as the fastest growing market for colorectal cancer screening. Rising healthcare expenditures and improving access to healthcare in countries such as China, India and Japan are driving the market growth. The economic growth in the region has enhanced the affordability of quality cancer care. Furthermore, rising incidence of colorectal cancer due to lifestyle changes and adoption of western diet prompts governments to take preventive measures. For instance, India has launched several public awareness campaigns to promote screening of colorectal cancer.